13F-HR filed by Ally Bridge Group (NY) LLC
Ally Bridge Group (NY) LLC filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 18 holding rows worth $76,289,095.
- Accession
- 0000950123-23-004992
- Filer
- CIK 1822947
- Filed
- 2023-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 18 entries on the cover page, a total value of $76,289,095 stated on the cover page (in dollars after the unit check, H1), rows summing to $76,289,095 with VALUE read as dollars as filed, 13F file number 028-20834. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFan Yu 028-20833
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 487,631 | $9,791,630 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 266,961 | $9,554,534 | dollars as filed | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 1,131,827 | $8,149,154 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 223,382 | $7,860,813 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 29,614 | $7,174,288 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 255,310 | $6,211,692 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 275,970 | $5,077,848 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 1,191,271 | $4,896,124 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871103 | COM | 2,517,232 | $4,556,190 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 20,830 | $2,870,999 | dollars as filed | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 550,000 | $2,310,000 | dollars as filed | |
| MEDAVAIL HOLDINGS INC | 58406B103 | COM | 5,894,897 | $1,689,477 | dollars as filed | |
| MDXHEALTH SA | 58286E102 | ADR | 500,000 | $1,620,000 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 72,850 | $1,558,262 | dollars as filed | |
| RAPID MICRO BIOSYSTEMS INC | 75340L104 | CLASS A COM | 699,664 | $916,560 | dollars as filed | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 236,583 | $702,652 | dollars as filed | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 109,393 | $683,706 | dollars as filed | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 249,126 | $665,166 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-23-004992 | this filing | 2023-05-15 | acceptance time not in the bulk data set |